Acquired Rifampicin Resistance in Thrice-Weekly Antituberculosis Therapy: Impact of HIV and Antiretr...
Acquired Rifampicin Resistance in Thrice-Weekly Antituberculosis Therapy: Impact of HIV and Antiretroviral Therapy
About this item
Full title
Author / Creator
Narendran, Gopalan , Menon, Pradeep Aravindan , Venkatesan, Perumal , Vijay, Krishnamoorthy , Padmapriyadarsini, Chandrasekaran , Kumar, Santhanakrishnan Ramesh , Bhavani, Kannabiran Perumal , Sekar, Lakshmanan , Gomathi, Sivaramakrishnan Narayan , Chandrasekhar, Chockalingam , Kumar, Satagopan , Sridhar, Rathinam and Swaminathan, Soumya
Publisher
Oxford: Oxford University Press
Journal title
Language
English
Formats
Publication information
Publisher
Oxford: Oxford University Press
Subjects
More information
Scope and Contents
Contents
Background. Risk factors for acquired rifampicin resistance (ARR) in human immunodeficiency virus (HIV)/tuberculosis coinfection, in the highly active antiretroviral therapy (HAART) era, needs evaluation. We studied the impact of HIV and HAART on ARR among patients taking thrice-weekly antituberculosis therapy. Methods. This cross-protocol analysis...
Alternative Titles
Full title
Acquired Rifampicin Resistance in Thrice-Weekly Antituberculosis Therapy: Impact of HIV and Antiretroviral Therapy
Authors, Artists and Contributors
Author / Creator
Menon, Pradeep Aravindan
Venkatesan, Perumal
Vijay, Krishnamoorthy
Padmapriyadarsini, Chandrasekaran
Kumar, Santhanakrishnan Ramesh
Bhavani, Kannabiran Perumal
Sekar, Lakshmanan
Gomathi, Sivaramakrishnan Narayan
Chandrasekhar, Chockalingam
Kumar, Satagopan
Sridhar, Rathinam
Swaminathan, Soumya
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1628526289
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1628526289
Other Identifiers
ISSN
1058-4838
E-ISSN
1537-6591
DOI
10.1093/cid/ciu674
